Studies related to Symptoms of Schizophrenia and CBD

Cannabidiol (CBD) As An Adjunctive Therapy In Schizophrenia: A Multicenter Randomized Controlled Trial

Effect Decrease
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 88
Sex n/a

Full details on all 2 studies are available to Examine Plus members.

Already a member? Login now to access.